当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 利润表

亿帆医药

(002019)

  

流通市值:118.73亿  总市值:171.63亿
流通股本:8.41亿   总股本:12.16亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入1,326,616,043.25,159,823,227.643,858,211,534.782,632,089,783.35
营业收入1,326,616,043.25,159,823,227.643,858,211,534.782,632,089,783.35
二、营业总成本1,200,723,203.714,758,180,864.673,531,892,029.962,363,162,281.95
营业成本711,260,943.922,713,055,053.042,019,896,584.591,374,809,781.73
税金及附加16,423,33950,441,891.0537,868,104.7129,528,550.8
销售费用313,628,723.361,220,889,028.37962,031,504.27638,226,395.9
管理费用87,010,401.46408,136,226.79279,807,921.91173,744,849.65
研发费用63,503,366.31291,966,914.3182,438,180.13114,594,982.81
财务费用8,896,429.6673,691,751.1249,849,734.3532,257,721.06
其中:利息费用13,375,730.4169,100,599.752,655,529.3733,443,730.44
其中:利息收入3,153,053.78,120,841.777,047,405.264,334,459.37
加:投资收益-7,259,252.11-14,164,575.31-6,930,848.09-1,288,863.23
资产处置收益-105,871.9130,145,653.6434,217,935.542,198,867.23
资产减值损失(新)-4,880,770.28-105,335,584.57-20,693,476.75-10,823,614.64
信用减值损失(新)-18,267,116.66-59,555,773.08-50,850,079.08-50,826,479.16
其他收益61,681,911.99129,078,098.9101,570,508.0583,284,962.09
营业利润平衡项目0000
四、营业利润157,061,740.52381,810,182.55383,633,544.49291,472,373.69
加:营业外收入106,799.1714,758,703.593,460,039.532,854,677.57
减:营业外支出485,840.787,911,933.862,036,783.86676,406.7
利润总额平衡项目0000
五、利润总额156,682,698.91388,656,952.28385,056,800.16293,650,644.56
减:所得税费用18,453,067.2965,035,239.6677,296,802.6581,204,665.33
六、净利润138,229,631.62323,621,712.62307,759,997.51212,445,979.23
持续经营净利润138,229,631.62323,621,712.62307,759,997.51212,445,979.23
归属于母公司股东的净利润153,161,633.89385,967,572.95366,380,130.89253,226,615.6
少数股东损益-14,932,002.27-62,345,860.33-58,620,133.38-40,780,636.37
(一)基本每股收益0.130.320.30.21
(二)稀释每股收益0.130.320.30.21
八、其他综合收益20,675,101.78-25,329,608.54-10,825,241.37-17,359,424.85
归属于母公司股东的其他综合收益20,234,459.93-25,621,468.38-10,798,610.7-17,384,862.25
九、综合收益总额158,904,733.4298,292,104.08296,934,756.14195,086,554.38
归属于母公司股东的综合收益总额173,396,093.82360,346,104.57355,581,520.19235,841,753.35
归属于少数股东的综合收益总额-14,491,360.42-62,054,000.49-58,646,764.05-40,755,198.97
公告日期2025-04-302025-04-282024-10-312024-08-15
审计意见(境内)标准无保留意见
TOP↑